Pharmaceutical drug opportunity assessment
Our insights and recommendations will give you the confidence to make the right strategic decisions at the early stages of commercialisation
Product development is the lifeblood of the pharmaceutical industry. But evaluating the wealth of potential opportunities at the early stages of drug discovery and commercialisation is fraught with uncertainty. We can help you to assess and evaluate opportunities systematically and comprehensively, using a range of qualitative research and quantitative research methods to answer questions such as:
- Where are the unmet needs in the marketplace?
- What is the viability of this product concept?
- What is the size of the market opportunity?
- What is the likely demand for this product?
- Where are the growth markets?
- What is the competitive landscape?
- What should our portfolio look like?
Custom research offerings include:
- Market access consulting
- Demand assessments and forecasting
- Concept evaluations
- Market and product analysis
- Portfolio planning
- Competitor analysis
- How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
The challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…read more »How we assessed the access potential of a new product in order to develop a successful launch strategy
Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.read more »Using demand assessment techniques to evaluate the market landscape and product opportunity
The challenge:Our client wanted to evaluate the potential of two treatments which would offer efficacy and side effects similar to those of biologics in atopic dermatitis. Therefore our client needed to understand more about the US and German market landscape in moderate-severe atopic dermatitis and how these advanced treatments might fit into the treatment algorithim when they are launched, as well as the potential drivers…read more »How the opportunity for a product treating a rare haematology disease in Emerging Markets was evaluated using a multi-stakeholder approach
Our client wanted to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging marketsread more »
- Some example case studiesHow we conducted conference research to understand physician reactions to abstracts presented in a virtual setting
Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO).read more »How we supported forecasting for a new vaccine by identifying the optimal pricing strategy
The challengeOur client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model. In parallel, they needed to ensure widespread and rapid market penetration of the vaccine, taking into account factors such as consumer socio-economic group, age and household composition.…read more »How we conducted rare disease patient research during the COVID-19 lockdown in China
The challengeOur client needed to conduct a small number of qualitative interviews in China with patients diagnosed with a rare condition which affects children and young adults. The results of the survey were time critical as they were needed to inform a protocol being published in 30 working days. We faced two key challenges, firstly to find, screen and recruit diagnosed patients with a prevalence…read more »